![The Cancer History Project: Building a living record of progress against cancer Reflecting on our impact—and most-read articles](https://cdn.cancerletter.com/media/2021/12/17180405/47-46-sign-NCA-4x3-1.jpg)
![The Cancer History Project: Building a living record of progress against cancer Reflecting on our impact—and most-read articles](https://cdn.cancerletter.com/media/2021/12/17180405/47-46-sign-NCA-4x3-1.jpg)
Cover Story
Cancer History ProjectEditorialFree
By Otis W. Brawley and Paul Goldberg
Forty-nine years and a few days after the signing of the National Cancer Act of 1971, we launched the Cancer History Project. One year and 11,894 articles later, we have built a shared, collaborative, and unprecedented resource.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
Drugs & Targets
Trending Stories
- FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Our challenge: To find zen in chaos
- Foundations acquire a critical new role as federal funding for cancer research falters
- Beyond the $500B Stargate Project: The frontier of AI in oncology beckons
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”